Literature DB >> 23054893

Cytoskeletal regulation of TRPC channels in the cardiorenal system.

Jonathan A Stiber1, Youlan Tang, TianYu Li, Paul B Rosenberg.   

Abstract

Transient receptor potential canonical (TRPC) channels have been implicated in several aspects of cardiorenal physiology including regulation of blood pressure, vasoreactivity, vascular remodeling, and glomerular filtration. Gain and loss of function studies also support the role of TRPC channels in adverse remodeling associated with cardiac hypertrophy and heart failure. This review discusses TRP channels in the cardiovascular and glomerular filtration systems and their role in disease pathogenesis. We describe the regulation of gating of TRPC channels in the cardiorenal system as well as the influence on activation of these channels by the underlying cytoskeleton and scaffolding proteins. We then focus on the role of TRP channels in the pathogenesis of adverse cardiac remodeling and as potential therapeutic targets in the treatment of heart failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054893      PMCID: PMC3532928          DOI: 10.1007/s11906-012-0313-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia.

Authors:  B Kumar; K Dreja; S S Shah; A Cheong; S-Z Xu; P Sukumar; J Naylor; A Forte; M Cipollaro; D McHugh; P A Kingston; A M Heagerty; C M Munsch; A Bergdahl; A Hultgårdh-Nilsson; M F Gomez; K E Porter; P Hellstrand; D J Beech
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 2.  Interplay between TRP channels and the cytoskeleton in health and disease.

Authors:  Kristopher Clark; Jeroen Middelbeek; Frank N van Leeuwen
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

3.  TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.

Authors:  Jochen Reiser; Krishna R Polu; Clemens C Möller; Peter Kenlan; Mehmet M Altintas; Changli Wei; Christian Faul; Stephanie Herbert; Ivan Villegas; Carmen Avila-Casado; Mary McGee; Hikaru Sugimoto; Dennis Brown; Raghu Kalluri; Peter Mundel; Paula L Smith; David E Clapham; Martin R Pollak
Journal:  Nat Genet       Date:  2005-05-27       Impact factor: 38.330

4.  TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells.

Authors:  Cécile Ingueneau; Uyen Huynh-Do; Bertrand Marcheix; Anne Athias; Philippe Gambert; Anne Nègre-Salvayre; Robert Salvayre; Cécile Vindis
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

5.  TRPC6 enhances angiotensin II-induced albuminuria.

Authors:  Jason Eckel; Peter J Lavin; Elizabeth A Finch; Nirvan Mukerji; Jarrett Burch; Rasheed Gbadegesin; Guanghong Wu; Brandy Bowling; Alison Byrd; Gentzon Hall; Matthew Sparks; Zhu Shan Zhang; Alison Homstad; Laura Barisoni; Lutz Birbaumer; Paul Rosenberg; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

6.  mRNA distribution analysis of human TRPC family in CNS and peripheral tissues.

Authors:  Antonio Riccio; Andrew D Medhurst; Cesar Mattei; Rosemary E Kelsell; Andrew R Calver; Andrew D Randall; Christopher D Benham; Menelas N Pangalos
Journal:  Brain Res Mol Brain Res       Date:  2002-12-30

Review 7.  Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow.

Authors:  Joseph E Brayden; Scott Earley; Mark T Nelson; Stacey Reading
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-01-21       Impact factor: 2.557

8.  Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture.

Authors:  Roberto Berra-Romani; Amparo Mazzocco-Spezzia; Maria V Pulina; Vera A Golovina
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

9.  Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity.

Authors:  Jonathan A Stiber; Zhu-Shan Zhang; Jarrett Burch; Jerry P Eu; Sarah Zhang; George A Truskey; Malini Seth; Naohiro Yamaguchi; Gerhard Meissner; Ripal Shah; Paul F Worley; R Sanders Williams; Paul B Rosenberg
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

10.  Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.

Authors:  Hiroyuki Nakayama; Benjamin J Wilkin; Ilona Bodi; Jeffery D Molkentin
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

View more
  6 in total

1.  Location and function of transient receptor potential canonical channel 1 in ventricular myocytes.

Authors:  Qinghua Hu; Azmi A Ahmad; Thomas Seidel; Chris Hunter; Molly Streiff; Linda Nikolova; Kenneth W Spitzer; Frank B Sachse
Journal:  J Mol Cell Cardiol       Date:  2020-01-23       Impact factor: 5.000

Review 2.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

3.  Mechanical transduction by ion channels: A cautionary tale.

Authors:  Frederick Sachs
Journal:  World J Neurol       Date:  2015-09-28

Review 4.  Cell mechanosensitivity: mechanical properties and interaction with gravitational field.

Authors:  I V Ogneva
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

5.  Transient receptor potential vanilloid type 4 is expressed in vasopressinergic neurons within the magnocellular subdivision of the rat paraventricular nucleus of the hypothalamus.

Authors:  F C Shenton; S Pyner
Journal:  J Comp Neurol       Date:  2018-11-06       Impact factor: 3.215

6.  Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways.

Authors:  Annunziatina Laurino; Valentina Spinelli; Manuela Gencarelli; Valentina Balducci; Leonardo Dini; Lorenzo Diolaiuti; Marco Ghionzoli; Antonio Messineo; Alessandro Mugelli; Elisabetta Cerbai; Laura Raimondi; Laura Sartiani
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.